Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

388

Participants

Timeline

Start Date

February 3, 2014

Primary Completion Date

May 8, 2015

Study Completion Date

May 8, 2015

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

semaglutide

Once weekly, administrated subcutaneously (s.c. under the skin)

DRUG

placebo

Once weekly, administrated subcutaneously (s.c. under the skin)

Trial Locations (86)

1739

Novo Nordisk Investigational Site, Krugersdorp

1818

Novo Nordisk Investigational Site, Johannesburg

1827

Novo Nordisk Investigational Site, Johannesburg

2129

Novo Nordisk Investigational Site, Vrededorp

4170

Novo Nordisk Investigational Site, eMkhomazi

4450

Novo Nordisk Investigational Site, Durban

6014

Novo Nordisk Investigational Site, Port Elizabeth

9301

Novo Nordisk Investigational Site, Bloemfontein

13682

Novo Nordisk Investigational Site, Bucharest

19056

Novo Nordisk Investigational Site, Levittown

20230

Novo Nordisk Investigational Site, Aguascalientes

28277

Novo Nordisk Investigational Site, Charlotte

28472

Novo Nordisk Investigational Site, Whiteville

29303

Novo Nordisk Investigational Site, Spartanburg

31406

Novo Nordisk Investigational Site, Savannah

32277

Novo Nordisk Investigational Site, Jacksonville

33015

Novo Nordisk Investigational Site, Miami

33016

Novo Nordisk Investigational Site, Miami Lakes

33026

Novo Nordisk Investigational Site, Pembroke Pines

33143

Novo Nordisk Investigational Site, Miami

33144

Novo Nordisk Investigational Site, Miami

33173

Novo Nordisk Investigational Site, Miami

33174

Novo Nordisk Investigational Site, Miami

33472

Novo Nordisk Investigational Site, Boynton Beach

35128

Novo Nordisk Investigational Site, Pell City

35216

Novo Nordisk Investigational Site, Birmingham

36207

Novo Nordisk Investigational Site, Anniston

38654

Novo Nordisk Investigational Site, Olive Branch

40504

Novo Nordisk Investigational Site, Lexington

43015

Novo Nordisk Investigational Site, Delaware

45255

Novo Nordisk Investigational Site, Cincinnati

46112

Novo Nordisk Investigational Site, Brownsburg

46131

Novo Nordisk Investigational Site, Franklin

53100

Novo Nordisk Investigational Site, Siena

56124

Novo Nordisk Investigational Site, Pisa

59101

Novo Nordisk Investigational Site, Billings

64620

Novo Nordisk Investigational Site, Monterrey

67226

Novo Nordisk Investigational Site, Wichita

68144

Novo Nordisk Investigational Site, Omaha

75230

Novo Nordisk Investigational Site, Dallas

77474

Novo Nordisk Investigational Site, Sealy

77478

Novo Nordisk Investigational Site, Sugar Land

77479

Novo Nordisk Investigational Site, Sugar Land

80920

Novo Nordisk Investigational Site, Colorado Springs

87102

Novo Nordisk Investigational Site, Albuquerque

89440

Novo Nordisk Investigational Site, Ciudad Madero

90057

Novo Nordisk Investigational Site, Los Angeles

90716

Novo Nordisk Investigational Site, Hawaiian Gardens

90717

Novo Nordisk Investigational Site, Lomita

91324

Novo Nordisk Investigational Site, Northridge

91763

Novo Nordisk Investigational Site, Montclair

95122

Novo Nordisk Investigational Site, Catania

120203

Novo Nordisk Investigational Site, Buzău

163001

Novo Nordisk Investigational Site, Arkhangelsk

163045

Novo Nordisk Investigational Site, Arkhangelsk

194358

Novo Nordisk Investigational Site, Saint Petersburg

195257

Novo Nordisk Investigational Site, Saint-Petesburg

355035

Novo Nordisk Investigational Site, Stavropol

410053

Novo Nordisk Investigational Site, Saratov

410469

Novo Nordisk Investigational Site, Oradea

420073

Novo Nordisk Investigational Site, Kazan'

454048

Novo Nordisk Investigational Site, Chelyabinsk

630047

Novo Nordisk Investigational Site, Novosibirsk

800578

Novo Nordisk Investigational Site, Galati

07823

Novo Nordisk Investigational Site, Belvidere

V6J 1S3

Novo Nordisk Investigational Site, Vancouver

R2V 4W3

Novo Nordisk Investigational Site, Winnipeg

N6P 1A9

Novo Nordisk Investigational Site, London

M3J 1N2

Novo Nordisk Investigational Site, Toronto

H4A 3T2

Novo Nordisk Investigational Site, Montreal

H9R 4S3

Novo Nordisk Investigational Site, Pointe-Claire

G8T 7A1

Novo Nordisk Investigational Site, Trois-Rivières

00133

Novo Nordisk Investigational Site, Roma

00168

Novo Nordisk Investigational Site, Rome

05100

Novo Nordisk Investigational Site, Terni

606-8507

Novo Nordisk Investigational Site, Kyoto-shi, Kyoto

565-0853

Novo Nordisk Investigational Site, Suita-shi, Osaka

103-0027

Novo Nordisk Investigational Site, Tokyo

103-0028

Novo Nordisk Investigational Site, Tokyo

160-0008

Novo Nordisk Investigational Site, Tokyo

010507

Novo Nordisk Investigational Site, Bucharest

0084

Novo Nordisk Investigational Site, Pretoria

CF5 4AD

Novo Nordisk Investigational Site, Cardiff

DD2 5NH

Novo Nordisk Investigational Site, Dundee

WA9 3DA

Novo Nordisk Investigational Site, St Helens

SA2 8PP

Novo Nordisk Investigational Site, Swansea

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT02054897 - Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes | Biotech Hunter | Biotech Hunter